Al-Ahmad A, Rand WM, Manjunath G, Konstam MA, Salem DN, Levey AS, Sarnak MJ. 2001. Reduced kidney function and anemia as risk factors for mortality in patients with left ventricular dysfunction. J Am Coll Cardiol38:955-962.
2.
Al Falluji N, Lawrence-Nelson J, Kostis JB, Lacy CR, Ranjan R, Wilson AC. 2002. Effect of anemia on 1-year mortality in patients with acute myocardial infarction. Am Heart J144:636-641.
3.
Arant CB, Wessel TR, Olson MB, Merz CNB, Sopko G, Rogers WJ, and others. Hemoglobin level is an independent predictor for adverse cardiovascular outcomes in women undergoing evaluation for chest pain: results from the NHLBI WISE study. J Am Coll Cardiol. Forthcoming
4.
Balducci L. 2003. Epidemiology of anemia in the elderly: information on diagnostic evaluation. J Am Geriatr Soc51:S2-S9.
5.
Bosi G, Crepez R, Gamberini MR. 2003. Left ventricular remodelling, and systolic and diastolic function in young adults with beta thalassaemia major: a Doppler echocardiographic assessment and correlation with haematological data. Heart89(7):762-766.
6.
Ezekowitz JA, McAlister FA, Armstrong PW. 2003. Anemia is common in heart failure and is associated with poor outcomes: insights from a cohort of 12,065 patients with new-onset heart failure. Circulation107:223-225.
Greenland P, Knoll MD, Stamler J, Neaton JD, Dyer AR, Garside DB, Wilson PW. 2003. Major risk factors as antecedents of fatal and nonfatal coronary heart disease events. JAMA290:891-897.
9.
Halcox JP, Schenke WH, Zalos G, Mincemoyer R, Prasad A, Waclawiw MA, Nour KR, Quyyumi AA. 2002. Prognostic value of coronary vascular endothelial dysfunction. Circulation106:653-658.
10.
Hampl H, Sternberg C, Berweck S, Lange D, Lorenz F, Pohle C, Riedel E, Gogoll L, Hennig L. 2002. Regression of left ventricular hypertrophy in hemodialysis patients is possible. Clin Nephrol58Suppl 1:S73-S96.
11.
Heller RF, Chinn S, Pedoe HD, Rose G. 1984. How well can we predict coronary heart disease? Findings in the United Kingdom Heart Disease Prevention Project. BMJ (Clin Res Ed)288:1409-1411.
12.
Hennekens CH. 1998. Increasing burden of cardiovascular disease: current knowledge and future directions for research on risk factors. Circulation97:1095-1102.
13.
Horwich TB, Fonarow GC, Hamilton MA, MacLellan WR, Borenstein J. 2002. Anemia is associated with worse symptoms, greater impairment in functional capacity and a significant increase in mortality in patients with advanced heart failure. J Am Coll Cardiol39:1780-1786.
14.
Jongen-Lavrencic M, Peeters HR, Wognum A, Vreugdenhil G, Breedveld FC, Swaak AJ. 1997. Elevated levels of inflammatory cytokines in bone marrow of patients with rheumatoid arthritis and anemia of chronic disease. J Rheumatol24:1504-1509.
15.
Keller TT, Mairuhu AT, de Kruif MD, Klein SK, Gerdes VE, ten Cate H, Brandjes DP, Levi M, van Gorp EC. 2003. Infections and endothelial cells. Cardiovasc Res60:40-48.
16.
Khot UN, Khot MB, Bajzer CT, Sapp SK, Ohman EM, Brener SJ, Ellis SG, Lincoff AM, Topol EJ. 2003. Prevalence of conventional risk factors in patients with coronary heart disease. JAMA290:898-904.
17.
Klungel OH, de Boer A, Paes AH, Seidell JC, Nagelkerke NJ, Bakker A. 1998. Undertreatment of hypertension in a population-based study in the Netherlands. J Hypertens16:1371-1378.
18.
KnuimanMW, Divitini ML, Olynyk JK, Cullen DJ, Bartholomew HC. 2003. Serum ferritin and cardiovascular disease: a 17-year follow-up study in Busselton, Western Australia. Am J Epidemiol158:144-149.
19.
Mantel-Teeuwisse AK, Verschuren WM, Klungel OH, Kromhout D, Lindemans AD, Avorn J, Porsius AJ, de Boer A. 2003. Undertreatment of hypercholesterolaemia: a population-based study. Br J Clin Pharmacol55:389-397.
20.
Merz CN, Kelsey SF, Pepine CJ, Reichek N, Reis SE, Rogers WJ, and others. 1999. The Women’s Ischemia Syndrome Evaluation (WISE) study: protocol, design, methodology, and feasibility report. J Am Coll Cardiol33:1453-1461.
21.
Muhlstein JB, Anderson JL. 2003. Chronic infection and coronary artery disease. Cardiol Clin21:333-362.
22.
Prasad A, Zhu J, Halcox JP, Waclawiw MA, Epstein SE, Quyyumi AA. 2002. Predisposition to atherosclerosis by infections: role of endothelial dysfunction. Circulation106:184-190.
23.
Quyyumi AA. 1998. Endothelial function in health and disease: new insights into the genesis of cardiovascular disease. Am J Med105:32S-39S.
24.
Quyyumi AA. 2003. Prognostic value of endothelial function. Am J Cardiol91Suppl:19H-24H.
25.
Ridker PM, Rifai N, Rose L, Buring JE, Cook NR. 2002. Comparison of C-reactive protein and low-density lipoprotein cholesterol levels in the prediction of first cardiovascular events. N Engl J Med347:1557-1565.
26.
Sarnak MJ, Tighiouart H, Manjunath G, MacLeod B, Griffith J, Salem D, Levey AS. 2002. Anemia as a risk factor for cardiovascular-disease in the Atherosclerosis Risk in Communities (ARIC) Study. J Am Coll Cardiol40:27-33.
27.
Saydah SH, Fradkin J, Cowie CC. 2004. Poor control of risk factors for vascular disease among adults with previously diagnosed diabetes. JAMA291:335-342.
28.
Silberberg J, Racine N, Barre P, Sniderman A. 1990. Regression of left ventricular hypertrophy in dialysis patients following correction of anemia with recombinant human erythropoietin. Can J Cardiol6:1-1.
29.
Silverberg DS, Wexler D, Blum M, Schwartz D, Keren G, Sheps D, Iaian A. 2003. Effect of correction of anemia with erythropoietin and intravenous iron in resistant heart failure in octogenarians. Isr Med Assoc J5(5):337-339.
30.
Spagnoli LG, Bonanno E, Mauriello A, Palmieri G, Partenzi A, Sangiorgi G, Crea F. 2002. Multicentric inflammation in epicardial coronary arteries of patients dying of acute myocardial infarction. J Am Coll Cardiol40:1579-1588.
31.
Vita JA, Keaney JF. 2002. Endothelial function: a barometer of cardiovascular risk?Circulation106:640-642.
32.
Widlansky ME, Gokce N, Keaney JF, Vita JA. 2003. The clinical implications of endothelial dysfunction. J Am Coll Cardiol42:1149-1160.
33.
Wu WC, Rathore SS, Wang Y, Radford MJ, Krumholz HM. 2001. Blood transfusion in elderly patients with acute myocardial infarction. N Engl J Med345:1230-1236.